close_game
close_game
[

serum institute of india news

]

Latest from serum institute of india

Meet Cyrus Poonawalla, Pune's richest man with a net worth of 2,04,300 crore

The ninth richest billionaire in the country, Poonawalla boasts a home worth ₹750 crore

Dr.Cyrus Poonawalla, started out as the son of a horse breeder, and now is one of the wealthiest individuals in the country.
Published on Oct 27, 2024 12:18 PM IST

Adar Poonawala on buying stake in Dharma productions: ‘My friend Karan Johar...’

Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Productions for 1000 crore, allowing Johar to maintain creative control.

Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India.
Updated on Oct 21, 2024 01:53 PM IST

SII to develop Mpox vaccine within a year

Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time

Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time. (REUTERS (PIC FOR REPRESENTATION))
Updated on Aug 21, 2024 08:00 AM IST
ByVicky Pathare

Pune’s Serum Institute ships malaria vaccine to African countries

Serum Institute of India ships R21/Matrix-M™ malaria vaccine to Africa, starting with Central African Republic. 163,800 doses allocated for CAR.

CEO of Serum Institute of India, Adar Poonawalla and Ambassador of the United States of America to India, Eric Garcetti flag off the first consignment of R21-Matrix-M Malaria vaccine doses to Africa, in Pune on Monday. (Eric Garcetti X/ANI)
Updated on May 21, 2024 07:36 AM IST
ByVicky Pathare

SII to acquire 20% stake in needle-free tech firm IntegriMedical

Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology

Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology. ((PIC FOR REPRESENTATION))
Updated on May 18, 2024 08:18 AM IST

All Covishield side-effects were disclosed: Serum Institute of India

Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.

The pharma giant has begun the worldwide withdrawal of its Covid-19 vaccine due to a ‘surplus of available updated vaccines’ that target new variants of the virus. (FILE PHOTO)
Updated on May 09, 2024 04:10 AM IST
ByVicky Pathare

Parents sue Serum Institute over daughter's death, allegedly due to Covishield

Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’

AstraZeneca has said that due to the same vaccine, blood clotting takes place and it can lead to a lowered platelete count. (Reuters/File)
Published on May 02, 2024 11:19 AM IST
By, New Delhi

Gaganyaan mission: PM Modi announces names of 4 astronauts, netizens react

PM bestowed astronaut wings to the astronauts selected for ISRO’s Gaganyaan mission. A video of the ceremony was also shared on Instagram.

The image shows PM Modi with the four astronauts selected for ISRO’s Gaganyaan mission. (Instagram/@https://www.hindustantimes.com/topic/gaganyaan)
Updated on Feb 27, 2024 03:02 PM IST
ByTrisha Sengupta

NASA shares an interesting puzzle with a cat emoji as a hint. Can you solve it?

Brain Teaser: Do you think you can solve this Hubble-related quiz by NASA?

Brain teaser: What do you think this Hubble image shows? (Instagram/@nasahubble)
Published on Feb 23, 2024 07:01 AM IST
ByTrisha Sengupta

Sharad Pawar proposes Bharat Ratna for Dr Ponawalla

Dr Poonawalla, the chairman and managing director of SII, on Wednesday, was conferred with the late Dr Mohan Dharia ‘Rashtra Nirman Puraskar’ for the year 2024

The award is a recognition of Dr Poonawalla’s significant contributions to national development, particularly in the field of public health through vaccine manufacturing. (HT PHOTO)
Updated on Feb 15, 2024 04:34 PM IST
ByVicky Pathare

Serum Institute's Adar Poonawalla invited to Ram Temple consecration: 'Humbled'

The industrialists who received the invitation include businessman Mukesh Ambani, Anil Ratan Tata, Gautam Adani, TS Kalyanaraman and the like.

Adar Poonawala receives invitation to Ram Temple consecration event.(X/Adar Poonawala)
Published on Jan 19, 2024 02:57 PM IST

Why rich Indians are buying marquee properties in London

Ultra-high net-worth individuals exploring the UK as an investment destination often have great cultural comfort and familiarity with the place.

Indian UHNIs are investing in properties in London as it is seen as a gateway destination, on account of business opportunities overseas, lifestyle, investment diversification and enhanced quality of education as well as life for their next generation.(Source: Pixabay)
Published on Dec 18, 2023 11:09 AM IST

Adar Poonawalla strikes a deal to buy London’s most expensive house of the year

Adar Poonawalla has agreed to pay the amount for a 25,000 square foot Mayfair mansion.

Adar Poonawalla, chief executive officer of Serum Institute of India (SII). (HT Photo)
Updated on Dec 12, 2023 10:36 PM IST

Pune-based Serum Institute to soon start Phase I & II trials of dengue vaccine in India

The Phase 1 and Phase 2 study of Dengusiil in India will be conducted on 45 adults of 18 years and above and 75 children of 2 years of age and above and less than (<) 18 years of age

After completion of the Phase 1/2 study, the Phase 3 study will be approved. (HT)
Updated on Nov 27, 2023 05:08 AM IST
ByVicky Pathare

Serum Institute founder Cyrus Poonawalla suffers cardiac arrest, undergoes angioplasty

Cyrus Poonawalla, chairman of Serum Institute of India, suffered a mild cardiac arrest and underwent angioplasty. He is recovering and will be discharged soon.

Cyrus Poonawalla, chairman and managing director, Serum Institute of India, was admitted at Ruby Hall Clinic on Friday early morning. (HT FILE PHOTO)
Updated on Nov 17, 2023 10:37 PM IST
ByVicky Pathare

Serum’s Cervavac vaccine for cervical cancer now in pvt hosps

Cervavac vaccine to fight cervical cancer has been developed and manufactured by the Pune-based Serum Institute of India (SII)

FILE PHOTO: A research scientist works inside a laboratory of India's Serum Institute. Cervavac vaccine to fight cervical cancer has been developed and manufactured by the Pune-based Serum Institute of India (SII). (REUTERS (PIC FOR REPRESENTATION))
Updated on Jul 18, 2023 12:54 AM IST
ByVicky Pathare

SII’s multivalent meningococcal meningitis vaccine gets WHO prequalification

It is also the only vaccine that prevents meningitis caused by meningococcal group X, a pathogen increasingly implicated in meningitis outbreaks in Africa

The vaccine protects against meningococcal serogroups A, C, W, Y, and X. (HT file image)
Updated on Jul 12, 2023 06:01 PM IST

RIL tops list of Indian companies, Serum Institute first among unlisted: Report

The Top 10 companies in India hold ₹71.5 lakh crore, accounting for 37% of GDP. 7 of them are headquartered in Mumbai. Here is the list:

Reliance Industries Limited's Mukesh Ambani (Left) and Serum Institute of India's Adar Poonawalla
Published on Jun 20, 2023 05:58 PM IST

HC restrains 2 influencers from posting defamatory content against SII, Covishield

The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.

HT Image
Updated on Jun 06, 2023 01:03 AM IST

Bombay HC restrains activists from posting defamatory content on SII, Covishield

The order was passed in an interim application filed by SII in a defamation suit seeking ₹100 crore in damages from social media influencers Yohan Tengra and Ambar Kori for allegedly posting objectionable content regarding Covishield

Serum Institute of India chief executive officer Adar Poonawalla. (File)
Updated on Jun 05, 2023 03:28 PM IST

ED attaches Zavaray Soli Poonawalla’s assets worth 41.64 crore in Worli

Enforcement Directorate seizes properties worth INR 41.64 crore belonging to Zavaray Soli Poonawalla and family over foreign exchange violation probe linked to Panama Papers.

Mumbai, February 22, 2015 : Behroze and Zavaray Poonawalla at the 26th Poonawalla Breeders Multi-Million (PBMM), race in Mumbai. (HT Photo) (Hindustan Times)
Updated on May 09, 2023 12:50 AM IST
ByAbhishek Sharan, Mumbai

‘Fema violation’ case: ED seizes 41.64cr assets of Pune bizman

The agency alleged that Zavareh Soli Poonawalla and his family members were accused of misuse of the Liberalised Remittance Scheme under the provisions of the Foreign Exchange Management Act.

A statement issued by the ED said it has “seized three immovable properties located at Ceejay house, Worli, Mumbai, worth <span class='webrupee'>₹</span>41.64 crore under the provisions of FEMA in its probe against Zavareh Soli Poonawalla and his family members”. (HT)
Updated on May 09, 2023 12:34 AM IST
By, New Delhi

UK Investment Min inaugurates British Trade office in Pune

According to a press release released by the British Deputy High Commission, India remains a priority market for the UK

PM Modi had visited city-based SERUM institute back in 2021. (HT PHOTO)
Updated on Apr 28, 2023 11:29 PM IST

Serum Institute of India to produce 5mn Covishield doses in two months

SII has made available five to six million Covovax doses even as the demand for it is still almost zero. We will produce the same amount of Covishield doses in the next two to three months, said Adar Poonawalla

Adar Poonawalla, chief executive officer of Serum Institute of India (SII). (HT PHOTO)
Updated on Apr 22, 2023 11:01 PM IST

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

SII chief Adar Poonawalla on Saturday said that the current Covid strain is not severe and the company has produced five to six million doses of Covovax.

SII chief executive officer Adar Poonawalla.
Published on Apr 22, 2023 03:08 PM IST

India's Serum Institute resumes Covishield production as Covid cases surge

SII CEO Adar Poonawalla says Covishield manufacturing has resumed, 6M Covovax booster doses ready, and manufacturers are ready but no demand yet.

Adar Poonawalla, CEO of Serum Institute of India (HT FILE PHOTO)
Published on Apr 12, 2023 05:38 PM IST
PTI | | Posted by Animesh Chaturvedi

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Last month, COVID-19 Working Group also recommended to the health ministry inclusion of Covovax on the CoWIN portal as a heterologous booster dose for adults.

The letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) on March 27, they said.(HT_PRINT)
Published on Apr 03, 2023 08:10 PM IST
PTI |

Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude

The R21 malaria vaccine, which is also known as Matrix-M, was designed at the Jenner Institute, University of Oxford, which collaborated with SII in 2020 to manufacture and develop the jab for large-scale supply.

According to WHO, malaria is a life-threatening disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes.
Published on Dec 06, 2022 08:33 AM IST
By, New Delhi

Serum Institute Whatsapp duping case: Seven held from various states

As per the First Information Report registered with Bundgarden police station in the second week of September, the accused had used Poonawalla's image in a Whatsapp account and sent messages about money transfer to Satish Deshpande, one of the directors of the firm.

Serum Institute of India CEO Adar Poonawalla.
Published on Nov 25, 2022 07:32 PM IST
PTI |

SII's Adar Poonawalla expects Omicron-specific vaccine in 6 months: Report

Adar Poonawalla's statement came even as the UK became the first country to authorise an updated version of Moderna's Covid-19 vaccine that includes protection against the Omicron variant.

Adar Poonawalla, CEO of Serum Institute of India (SII), the world's biggest vaccine maker.(REUTERS file)
Published on Aug 15, 2022 11:36 PM IST
By, New Delhi
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, December 05, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On